New data supports the idea that Merck’s Ebola vaccine Ervebo, licensed to target the Zaire species of ebolaviruses, could ...
A stepwise HIV vaccine strategy has induced broadly neutralizing antibodies in primates, hinting that a truly protective HIV ...
Vaxcyte's VAX-31 is in a Phase 3 pivotal OPUS-1 noninferiority trial and is expecting topline data in 4Q 2026. Learn more ...
Fact check - The narrative mixes a number of scientific terms related to vaccines and then draws a false conclusion.
India has approved QDENGA, its first dengue vaccine. A pulmonary specialist explains who should get vaccinated, who should ...
Qdenga, cleared this week for ages 4 to 60, is one of only a few dengue vaccines in the world. It is to be injected in two ...
AI-led approaches to vaccine design are expanding rapidly, with the number of research papers on AI-enabled vaccine development increasing by 5,200% over the past 10 years, according to data from ...
Experimental KRAS Vaccine Generates Immune Response Against Pancreatic Cancer in People at High Risk
Researchers at the Johns Hopkins Kimmel Cancer Center and its Skip Viragh Center for Pancreatic Cancer report that an ...
The trial could begin within two weeks if it receives regulatory and ethical approval, the Addis Ababa-based agency said in ...
ICMR licensed three indigenous biomedical technologies to Emcure and Biological E, advancing an HPV precancer therapy and vaccines for typhoid, paratyphoid and Shigella toward affordable commercial ...
A first-in-human KRAS-targeted pancreatic cancer vaccine elicited durable immune responses in 90% of participants, and slowed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results